DoW Melanoma Research Program Focused Program Award ? Rare Melanomas

The DoW Melanoma Research Program Focused Program Award – Rare Melanomas supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas. The program requires an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs. The maximum period of performance is 4 years, and the Congressionally Directed Medical Research Programs expects to allot roughly $5.6M to fund approximately two Focused Program Award – Rare Melanomas applications with total cost caps of $2.8M per award. Key features of the program include: * Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team. * Clinical trials are allowed. * The program seeks to fund research across the entire cancer research spectrum addressing unmet needs and knowledge gaps associated with rare melanomas. * The program has a two-step application process, with a pre-application submission deadline of July 13, 2026, and an application submission deadline of October 14, 2026.